维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

1篇 您的检索式：作者名="Mark Radlinski"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Role of endoscopic ultrasound in esophageal cancer显示文摘Esophageal cancer(ECA)affects 1 in 125 men and 1 in 417 for women and accounts for 2.6%of all cancer related deaths in the United States.The associated survival rate depends on the stage of the cancer at the time of diagnosis,making adequate work up and staging imperative.The 5-year survival rate for localized disease is 46.4%,regional disease is 25.6%,and distant/metastatic disease is 5.2%.Additionally,treatment is stage-dependent,making staging all that much important.For nonmetastatic transmural tumors(T3)and/or those that have locoregional lymph node involvement(N),neoadjuvant therapy is recommended.Conversely,for those who have earlier tumors,upfront surgical resection is reasonable.While positron emission tomography/computed tomography and other cross sectional imaging modalities are exceptional for detecting distant disease,they are inaccurate in staging locoregional disease.Endoscopic ultrasound(EUS)has played a key role in the locoregional(T and N)staging of newly diagnosed ECA and has an evolving role in restaging after neoadjuvant therapy.There is even data to support that the use of EUS facilitates proper triaging of patients and may ultimately save money by avoiding unnecessary or futile treatment.This manuscript will review the current role of EUS on staging and restaging of ECA.	Mark Radlinski Vanessa M Shami	2022	World Journal of Gastrointestinal Endoscopy2022，14，4：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费